TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 48 filers reported holding TALIS BIOMEDICAL CORP in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $223,841 | -3.1% | 466,336 | -1.1% | 0.00% | – |
| Q1 2023 | $230,998 | +4.9% | 471,426 | -4.6% | 0.00% | – |
| Q4 2022 | $220,247 | -36.0% | 494,161 | -2.2% | 0.00% | – |
| Q3 2022 | $344,000 | -23.6% | 505,086 | -8.7% | 0.00% | – |
| Q2 2022 | $450,000 | -47.9% | 553,373 | -9.6% | 0.00% | – |
| Q1 2022 | $864,000 | -70.3% | 612,432 | -15.5% | 0.00% | – |
| Q4 2021 | $2,907,000 | -18.2% | 725,133 | +27.5% | 0.00% | – |
| Q3 2021 | $3,555,000 | -40.9% | 568,757 | +4.4% | 0.00% | – |
| Q2 2021 | $6,011,000 | +19.9% | 544,906 | +39.7% | 0.00% | – |
| Q1 2021 | $5,012,000 | – | 390,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 1,569,300 | $6,293,000 | 0.36% |
| ArrowMark Colorado Holdings LLC | 4,915,239 | $19,710,000 | 0.16% |
| Baker Brothers Advisors | 7,624,835 | $30,576,000 | 0.15% |
| Golden State Equity Partners | 22,133 | $89,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 188,269 | $755,000 | 0.02% |
| PDT Partners, LLC | 34,890 | $140,000 | 0.01% |
| PERSONAL CFO SOLUTIONS, LLC | 10,000 | $40,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,500 | $130,000 | 0.00% |
| Qube Research & Technologies Ltd | 59,161 | $237,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 78,628 | $315,000 | 0.00% |